These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22273849)

  • 21. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen.
    Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C; Finarelli AC; de Bianchi PS; Bucchi L
    BMC Med; 2010 Feb; 8():11. PubMed ID: 20122145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of false-positive mammography on subsequent screening attendance and risk of cancer.
    McCann J; Stockton D; Godward S
    Breast Cancer Res; 2002; 4(5):R11. PubMed ID: 12223128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
    Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
    J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
    Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
    Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early breast cancer deaths in women aged 40-74 years diagnosed during the first 5 years of organised mammography service screening in north Sweden.
    Bordás P; Jonsson H; Nyström L; Cajander S; Lenner P
    Breast; 2004 Aug; 13(4):276-83. PubMed ID: 15325661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
    Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
    Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast screening: axillary lymph node status of interval cancers by interval year.
    Bucchi L; Puliti D; Ravaioli A; Cortesi L; De Lisi V; Falcini F; Ferretti S; Frigerio A; Mangone L; Petrella M; Petrucci C; Sassoli de Bianchi P; Traina A; Tumino R; Zanetti R; Zorzi M; Paci E
    Breast; 2008 Oct; 17(5):477-83. PubMed ID: 18455401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
    Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
    Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.
    Rayson D; Payne JI; Abdolell M; Barnes PJ; MacIntosh RF; Foley T; Younis T; Burns A; Caines J
    Clin Breast Cancer; 2011 Mar; 11(1):27-32. PubMed ID: 21421519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between mammographic breast density and breast cancer tumor characteristics.
    Aiello EJ; Buist DS; White E; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):662-8. PubMed ID: 15767347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
    Crouchley K; Wylie E; Khong E
    J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
    Bancej C; Decker K; Chiarelli A; Harrison M; Turner D; Brisson J
    J Med Screen; 2003; 10(1):16-21. PubMed ID: 12790311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
    Biesheuvel C; Czene K; Orgeás CC; Hall P
    Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower sensitivity of screening mammography after previous benign breast surgery.
    van Breest Smallenburg V; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; van Beek M; Louwman MW
    Int J Cancer; 2012 Jan; 130(1):122-8. PubMed ID: 21328339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using mammographic density to improve breast cancer screening outcomes.
    Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.